Spine and orthopedic biomaterials company FzioMed has appointed Paul Mraz as its new president and CEO, effective Jan. 1.
Mr. Mraz has taken over following the retirement of John Krelle, who served in the role for 18 years.
Previously, Mr. Mraz served as president and CEO of ApiFix, a biomaterials company that was acquired by OrthoPediatrics in 2020. Following the acquisition, he continued to serve as the senior vice president and general manager of the scoliosis franchise.
"Paul is a seasoned leader with a successful track record of execution and shareholder value creation across numerous medical device businesses worldwide," Ron Haynes, executive chairman of the FzioMed board, said in a Jan. 3 press release. "He brings an incredible amount of energy and strategic skills to the company as well as a deep understanding of global surgical markets."